Anaptysbio (ANAB) EBT Margin (2016 - 2026)
Anaptysbio (ANAB) posted EBT Margin of -206.78% for Q1 2026, down 65.32 percentage points from -141.46% a year earlier and down 252.69 percentage points from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) EBT Margin (2016 - 2026) Analysis & Trends
For the trailing twelve months through Mar 31, 2026, EBT Margin at Anaptysbio was -11.46%, up 114.20 percentage points year-over-year; for FY2025, it came in at -5.57%, up 153.53 percentage points from FY2024.
- Annual EBT Margin has increased for three consecutive years, with a five-year change of +21.00 percentage points (FY2020 to FY2025).
- In prior years, Anaptysbio's EBT Margin was -159.10% in FY2024 (+794.58 pp), -953.68% in FY2023 (+297.41 pp), -1251.09% in FY2022 (-1159.61 pp) and -91.49% in FY2021 (-64.91 pp).
- The Q1 2026 figure stands as the lowest quarterly EBT Margin since Q2 2024.
- On a year-over-year basis, EBT Margin increased in seven of the last eight quarters, with an average year-over-year change of +380.30 percentage points.
- The strongest year-over-year quarter for EBT Margin in the past five years was Q4 2022, with a gain of 2749.96 percentage points; the weakest was Q4 2021, with a drop of 3131.15 percentage points.
- According to Business Quant data, EBT Margin for the three prior quarters was 45.91% (Q4 2025), 19.80% (Q3 2025) and -173.34% (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Anaptysbio | 1.46 Bn | 349.53 Mn | - | -206.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -206.78% |
| Dec 31, 2025 | 45.91% |
| Sep 30, 2025 | 19.80% |
| Jun 30, 2025 | -173.34% |
| Mar 31, 2025 | -141.46% |
| Dec 31, 2024 | -50.54% |
| Sep 30, 2024 | -109.44% |
| Jun 30, 2024 | -425.22% |
| Mar 31, 2024 | -612.01% |
| Dec 31, 2023 | -468.80% |
| Sep 30, 2023 | -1,124.41% |
| Jun 30, 2023 | -1,151.59% |
| Mar 31, 2023 | -2,905.02% |
| Dec 31, 2022 | -325.12% |
| Sep 30, 2022 | -2,116.86% |
| Jun 30, 2022 | -2,195.07% |
| Mar 31, 2022 | -3,237.84% |
| Dec 31, 2021 | -3,075.07% |
| Sep 30, 2021 | -32.07% |
| Jun 30, 2021 | -1.43% |
API Access
Anaptysbio EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();